Literature DB >> 31857708

Assessing relatives' readiness for hereditary cancer cascade genetic testing.

Erica M Bednar1,2, Charlotte C Sun3, Sheryl McCurdy4, Sally W Vernon4.   

Abstract

PURPOSE: To explore the readiness of living, untested first-degree relatives (FDRs) to have cascade genetic testing (CGT) for a hereditary predisposition to cancer.
METHODS: Adults with a hereditary predisposition to cancer completed an anonymous, online survey about their genetic testing and their FDRs' vital status, awareness of the variant, uptake of CGT, and readiness for CGT among living, untested FDRs using transtheoretical model stages of change.
RESULTS: One hundred fifty participants completed the survey and reported 825 FDRs. Overall, 70.3% of FDRs were reportedly aware of the variant and 30.5% had completed CGT. Siblings had higher rates of awareness and CGT than parents or children (p < 0.001). Relatives' sex was associated with awareness and CGT; mothers were aware and had CGT at higher rates than fathers (p = 0.049 and p < 0.001), sisters were aware and had CGT at higher rates than brothers (p = 0.041 and p = 0.002), and daughters had higher rates of awareness than sons (p = 0.038). Of 340 living, untested FDRs, 79.4% were in the precontemplation stage of change, with no difference by relatives' sex or relationship to the participant.
CONCLUSIONS: Most living, untested FDRs were in precontemplation stage, indicating they are not ready or planning to have CGT within the next six months.

Entities:  

Keywords:  cascade testing; genetic testing; hereditary cancer; stage of change; transtheoretical model

Mesh:

Year:  2019        PMID: 31857708     DOI: 10.1038/s41436-019-0735-3

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  1 in total

1.  Membrane currents in a developing parasympathetic ganglion.

Authors:  C R Bader; D Bertrand; A C Kato
Journal:  Dev Biol       Date:  1983-08       Impact factor: 3.582

  1 in total
  3 in total

1.  Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases.

Authors:  Karin Kast; Julia Häfner; Evelin Schröck; Arne Jahn; Carmen Werner; Cornelia Meisel; Pauline Wimberger
Journal:  Breast Care (Basel)       Date:  2021-06-17       Impact factor: 2.268

2.  IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.

Authors:  Deborah Cragun; Jason Beckstead; Meagan Farmer; Gillian Hooker; Marleah Dean; Ellen Matloff; Sonya Reid; Ann Tezak; Anne Weidner; Jennifer G Whisenant; Tuya Pal
Journal:  BMC Cancer       Date:  2021-10-13       Impact factor: 4.430

3.  Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.

Authors:  Samantha Pollard; Steve Kalloger; Deirdre Weymann; Sophie Sun; Jennifer Nuk; Kasmintan A Schrader; Dean A Regier
Journal:  Health Expect       Date:  2020-04-27       Impact factor: 3.377

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.